32. RESEARCH ON SOME SIDE EFFECTS IN CHILDREN AFTER THE FIRST DOSE OF COVID-19 VACCINATION AT THE PEDIATRIC CENTER OF BACH MAI HOSPITAL

Nguyen Thanh Nam1, Pham Van Hung1, Do Hoang Hai1, Trinh Thinh Linh1, Pham Van Dem2
1 Bach Mai Hospital
2 University of Medicine and Pharmacy, Vietnam National University, Hanoi

Main Article Content

Abstract

Objective: To describe side effects impact on children after the first dose of an mRNA Covid-19 vaccine injection at the pediatric center of Bach Mai Hospital.


Subject and methods: A descriptive study was conducted on 61 children ages 12 years after the first dose of an mRNA Covid-19 vaccine injection had clinical symptoms admitted to the pediatric center of Bach Mai Hospital.


Results: The study collected 61 children, including 32 females and 29 males. The male/female ratio was 0,9/1. The most common symptom onset time is 2-7 days after vaccination, with a rate of 52.5%. The most typical clinical symptoms are chest pain (52.5%), shortness of breath 32.8%, fatigue 29.5%, and other clinical symptoms such as fever, dizziness, nausea, palpitations, and headache. There were 7 patients with anaphylaxis accounting for 11.5%, of which 3 patients had grade 3 anaphylaxis, accounting for 4.9%. The most common subclinical symptom is leukocytosis, which accounts for 9/50 children, 18% of which have an increased Troponin T index, an average Troponin index of 63.07±182 ng/l, there are 5 /61 accounted for 8.2% of patients had arrhythmia, 8/61 had ST elevation on electrocardiogram, accounting for 13.1%.


Conclusion: Clinical and subclinical symptoms of children over 12 years old are usually mild, moderate and fast recover after treatment.

Article Details

References

[1] Ban biên tập trang thông tin điện tử Cục Y tế dự
phòng, Tình hình dịch COVID-19 trên thế giới
và khuyến nghị của WHO, 2023.
[2] Hause AM, Baggs J, Marquez P et al., COVID-19
Vaccine Safety in Children Aged 5-11 Years
- United States, November 3-December 19,
2021. MMWR Morb Mortal Wkly Rep.
2021;70(5152):1755-1760. doi:10.15585/mmwr.
mm705152a1
[3] Bộ Y tế, Hướng dẫn tiêm vắc xin phòng
COVID19 cho trẻ em, Chiến dịch tiêm vắc xin
phòng COVID-19 cho trẻ em từ 5 đến dưới 12
tuổi, 2022
[4] Ngô Quý Châu, Triệu chứng học nội khoa tập 1,
Nhà xuất bản Y học, Hà Nội, 2020.
[5] Nguyễn Văn Bàng, Bài giảng nhi khoa tập 2,
Nhà xuất bản Y học, Hà Nội, 2020.
[6] Bộ Y tế, Hướng dẫn phòng chẩn đoán và xử trí
phản vệ mới nhất, Thông tư số 51/2017/TT-BYT
ngày 29 tháng 12 năm 2017 của Bộ trưởng Bộ
Y tế
[7] Bộ Y tế, Hướng dẫn chẩn đoán và xử trí một số
bệnh thường gặp ở trẻ em, Quyết định số 3312/
QĐ-BYT ngày 07/8/2015 của Bộ trưởng Bộ Y tế
[8] Klein NP, Demarco M, Fleming-Dutra KE et
al., Effectiveness of BNT162b2 COVID-19
Vaccination in Children and Adolescents,
Pediatrics, 2023;151(5):e2022060894.
doi:10.1542/peds.2022-060894
[9] Hause AM, Shay DK, Klein NP et al., Safety
of COVID-19 Vaccination in United States
Children Ages 5 to 11 Years, Pediatrics,
2022;150(2):e2022057313. doi:10.1542/
peds.2022-057313
[10] Dionne A, Sperotto F, Chamberlain S et al.,
Association of Myocarditis With BNT162b2
Messenger RNA COVID-19 Vaccine in a Case
Series of Children. JAMA Cardiol. 2021;6(12):1-
6. doi:10.1001/jamacardio, 2021.3471
[11] Chou OHI, Mui J, Chung CT et al., COVID-19
vaccination and carditis in children and
adolescents: a systematic review and metaanalysis.
Clin Res Cardiol. 2022;111(10):1161-
1173. doi:10.1007/s00392-022-02070-7
[12] Chiu SN, Chen YS, Hsu CC et al., Changes of
ECG parameters after BNT162b2 vaccine in
the senior high school students. Eur J Pediatr.
2023;182(3):1155-1162. doi:10.1007/s00431-
022-04786-0
[13] Feng Y, Quan Y, Cassady K, Clinical
characteristics in immune thrombocytopenia
patients after COVID-19 vaccination. Hum
Vaccin Immunother. 18(6):2119043. doi:10.108
0/21645515.2022.2119043
[14] Manno EC, Amodio D, Cotugno N et al., Higher
Troponin Levels on Admission are associated
With Persistent Cardiac Magnetic Resonance
Lesions in Children Developing Myocarditis
After mRNA-Based COVID-19 Vaccination.
Pediatr Infect Dis J. 2023;42(2):166-171.
doi:10.1097/INF.0000000000003762
[15] Truong DT, Dionne A, Muniz JC et al.,
Clinically Suspected Myocarditis Temporally
Related to COVID-19 Vaccination in
Adolescents and Young Adults: Suspected
Myocarditis After COVID-19 Vaccination,
Circulation, 2022;145(5):345-356. doi:10.1161/
CIRCULATIONAHA.121.056583
[16] Ozaka S, Kobayashi T, Mizukami K et al.,
COVID-19 vaccination and liver disease.
World J Gastroenterol. 2022;28(48):6791-6810.
doi:10.3748/wjg.v28.i48.6791.